Fusion — 2025 Investments
3 investments dated 2025 · listed companies and verified rows first · show all
Palo Alto, US
Board seatDavid Gerster· per SEC Form D · $4.9M raise · filed Mar 2025
Wilmington, US
Thore Buergel(Executive Officer, Director, Promoter)Jakob Steinfeldt(Executive Officer, Director)
Co-investorsCompoundHummingbird VenturesAnanda Impact Ventures
Cellular Intelligence is a cell therapy company developing engineered cell treatments for diseases, including a Phase 2-ready therapy for Parkinson's disease acquired from Novo Nordisk.
AI & Machine LearningBiotechDeep TechBoston, US
Micha Breakstone, Ph.D.(CEO & co-founder)Allon Klein, Ph.D.(Scientific Co-founder)Olivier Pourquié, Ph.D.(Scientific Co-founder)Cliff Tabin, Ph.D.(Scientific Co-founder)Jay Shendure, M.D., Ph.D.(Scientific Co-founder)Micah Breakstone(Executive Officer, Director, Promoter)
Co-investorsKhosla VenturesNext Coast VenturesSamsung NextAMD VenturesLerer HippeauMontage Ventures+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.